1. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
   Melayshia McFadden et al, 2021, Cancers CrossRef
2. Potential of Zinc Oxide Nanoparticles as an Anticancer Agent: A Review
   Hemaroopini Subramaniam et al, 2022, J Exp Bio & Ag Sci CrossRef
3. Conventional to Nanoscale-Based Carrier Systems in the Management of Ovarian Cancer
   Sabya Sachi Das et al, 2022 CrossRef
4. New trends in diagnosing and treating ovarian cancer using nanotechnology
   Juan Zhang et al, 2023, Front. Bioeng. Biotechnol. CrossRef
5. Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins
   Sophia Steinlein et al, 2023, Front. Oncol. CrossRef
6. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer
   Saika Saman et al, 2024, CCDT CrossRef
7. Interplay between paclitaxel, gap junctions, and kinases: unraveling mechanisms of action and resistance in cancer therapy
   Dong-Oh Moon, 2024, Mol Biol Rep CrossRef
8. The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers
   Vahideh Keyvani et al, 2024, CPD CrossRef
9. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies
   Yingfeng Zhang et al, 2024, ACS Omega CrossRef